metformin has been researched along with Muscular Diseases in 6 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Muscular Diseases: Acquired, familial, and congenital disorders of SKELETAL MUSCLE and SMOOTH MUSCLE.
| Excerpt | Relevance | Reference |
|---|---|---|
| " To investigate the effects of metformin on myopathy risks when added to preexisting statin therapy in dyslipidemia patients, we performed a retrospective cohort study using the Korean national health insurance data in statin-treated dyslipidemia patients with or without concomitant metformin use." | 8.31 | Impact of metformin on statin-associated myopathy risks in dyslipidemia patients. ( Bak, K; Choi, YJ; Ko, M; Moon, S; Shin, S, 2023) |
| "A detrimental consequence of hypermethylation is hyperhomocysteinemia (HHcy), that causes oxidative stress, inflammation, and matrix degradation, which leads to multi-pathology in different organs." | 4.95 | Hypermethylation: Causes and Consequences in Skeletal Muscle Myopathy. ( Behera, J; Jeremic, N; Majumder, A; Tyagi, SC, 2017) |
| " To investigate the effects of metformin on myopathy risks when added to preexisting statin therapy in dyslipidemia patients, we performed a retrospective cohort study using the Korean national health insurance data in statin-treated dyslipidemia patients with or without concomitant metformin use." | 4.31 | Impact of metformin on statin-associated myopathy risks in dyslipidemia patients. ( Bak, K; Choi, YJ; Ko, M; Moon, S; Shin, S, 2023) |
| "A 28-year-old Taiwanese woman presented with dyspnoea, poor appetite, and muscle weakness after using antiobesity drugs, including metformin, triiodothyronine, and topiramate." | 4.02 | Exacerbation of myopathy triggered by antiobesity drugs in a patient with multiple acyl-CoA dehydrogenase deficiency. ( Liang, WC; Liao, WA; Lin, PY; Sun, YT, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bak, K | 1 |
| Moon, S | 1 |
| Ko, M | 1 |
| Choi, YJ | 1 |
| Shin, S | 1 |
| Lin, PY | 1 |
| Liang, WC | 1 |
| Liao, WA | 1 |
| Sun, YT | 1 |
| Paun, DL | 1 |
| Vija, L | 1 |
| Stan, E | 1 |
| Banica, A | 1 |
| Bobeica, E | 1 |
| Terzea, D | 1 |
| Poiana, C | 1 |
| Badiu, C | 1 |
| Paun, S | 1 |
| Majumder, A | 1 |
| Behera, J | 1 |
| Jeremic, N | 1 |
| Tyagi, SC | 1 |
| Ledl, M | 1 |
| Hohenecker, J | 1 |
| Francesconi, C | 1 |
| Roots, I | 1 |
| Bauer, MF | 1 |
| Roden, M | 1 |
| Duwoos, H | 1 |
| Bertrand, CM | 1 |
| Husson, A | 1 |
| Cramer, J | 1 |
| Tayot, J | 1 |
1 review available for metformin and Muscular Diseases
| Article | Year |
|---|---|
Hypermethylation: Causes and Consequences in Skeletal Muscle Myopathy.
Topics: Animals; DNA Methylation; Epigenesis, Genetic; Folic Acid; Histones; Homocysteine; Humans; Hyperhomo | 2017 |
5 other studies available for metformin and Muscular Diseases
| Article | Year |
|---|---|
Impact of metformin on statin-associated myopathy risks in dyslipidemia patients.
Topics: Cohort Studies; Dyslipidemias; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic | 2023 |
Exacerbation of myopathy triggered by antiobesity drugs in a patient with multiple acyl-CoA dehydrogenase deficiency.
Topics: Adult; Anti-Obesity Agents; Asian People; Carnitine; Female; Humans; Metformin; Multiple Acyl Coenzy | 2021 |
Cushing syndrome secondary to ectopic adrenocorticotropic hormone secretion from a Meckel diverticulum neuroendocrine tumor: case report.
Topics: ACTH Syndrome, Ectopic; Adrenocorticotropic Hormone; Adult; Corticotropin-Releasing Hormone; Cushing | 2015 |
Acute myopathy in a type 2 diabetic patient on combination therapy with metformin, fenofibrate and rosiglitazone.
Topics: Aged; Creatine Kinase; Diabetes Mellitus, Type 2; Drug Interactions; Electromyography; Fenofibrate; | 2005 |
[Reversible hyperlactatemia induced by phenformin with muscular asthenia and cardio-respiratory signs].
Topics: Aged; Animals; Asthenia; Diabetes Complications; Diabetic Ketoacidosis; Dyspnea; Heart Diseases; Hep | 1970 |